Werewolf Therapeutics Inc’s filing revealed that its Director RA CAPITAL MANAGEMENT, L.P. acquired Company’s shares for reported $0.28 million on May 12 ’25. In the deal valued at $0.86 per share,320,913 shares were bought. As a result of this transaction, RA CAPITAL MANAGEMENT, L.P. now holds 6,021,969 shares worth roughly $6.68 million.
Then, RA CAPITAL MANAGEMENT, L.P. bought 162,539 shares, generating $159,288 in total proceeds. Upon buying the shares at $0.98, the Director now owns 6,237,482 shares.
Before that, RA CAPITAL MANAGEMENT, L.P. bought 52,974 shares. Werewolf Therapeutics Inc shares valued at $51,915 were divested by the Director at a price of $0.98 per share. As a result of the transaction, RA CAPITAL MANAGEMENT, L.P. now holds 6,074,943 shares, worth roughly $6.74 million.
JMP Securities initiated its Werewolf Therapeutics Inc [HOWL] rating to a Mkt outperform in a research note published on April 03, 2024; the price target was $12. A number of analysts have revised their coverage, including Wedbush’s analysts, who began to cover the stock in late August with a ‘”an Outperform”‘ rating. BofA Securities started covering the stock on September 10, 2021. It rated HOWL as “a Buy”.
Price Performance Review of HOWL
On Friday, Werewolf Therapeutics Inc [NASDAQ:HOWL] saw its stock unchanged to $1.11. Over the last five days, the stock has gained 38.78%. Werewolf Therapeutics Inc shares have fallen nearly -25.00% since the year began. Nevertheless, the stocks have fallen -77.48% over the past one year. While a 52-week high of $5.73 was reached on 01/03/25, a 52-week low of $0.60 was recorded on 04/07/25. SMA at 50 days reached $0.9551, while 200 days put it at $1.6453.
Levels Of Support And Resistance For HOWL Stock
The 24-hour chart illustrates a support level at 1.0700, which if violated will result in even more drops to 1.0300. On the upside, there is a resistance level at 1.1500. A further resistance level may holdings at 1.1900. The Relative Strength Index (RSI) on the 14-day chart is 62.43, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1259, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 28.72%. Stochastics %K at 70.98% indicates the stock is a holding.
The most recent change occurred on May 25, 2021 when SVB Leerink began covering the stock and recommended ‘”an Outperform”‘ rating along with a $29 price target.
